These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 12197900)

  • 1. Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis.
    van der Geld YM; Tool AT; Videler J; de Haas M; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG; Roos D
    Clin Exp Immunol; 2002 Sep; 129(3):562-70. PubMed ID: 12197900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis.
    Dolman KM; Stegeman CA; van de Wiel BA; Hack CE; von dem Borne AE; Kallenberg CG; Goldschmeding R
    Clin Exp Immunol; 1993 Sep; 93(3):405-10. PubMed ID: 8370167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complexes between proteinase 3, alpha 1-antitrypsin and proteinase 3 anti-neutrophil cytoplasm autoantibodies: a comparison between alpha 1-antitrypsin PiZ allele carriers and non-carriers with Wegener's granulomatosis.
    Baslund B; Szpirt W; Eriksson S; Elzouki AN; Wiik A; Wieslander J; Petersen J
    Eur J Clin Invest; 1996 Sep; 26(9):786-92. PubMed ID: 8889441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis.
    Daouk GH; Palsson R; Arnaout MA
    Kidney Int; 1995 Jun; 47(6):1528-36. PubMed ID: 7643521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity.
    van de Wiel BA; Dolman KM; van der Meer-Gerritsen CH; Hack CE; von dem Borne AE; Goldschmeding R
    Clin Exp Immunol; 1992 Dec; 90(3):409-14. PubMed ID: 1458677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides.
    Van Der Geld YM; Simpelaar A; Van Der Zee R; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG
    Kidney Int; 2001 Jan; 59(1):147-59. PubMed ID: 11135067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma.
    Baslund B; Petersen J; Permin H; Wiik A; Wieslander J
    J Immunol Methods; 1994 Oct; 175(2):215-25. PubMed ID: 7930650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis.
    Muller Kobold AC; Kallenberg CG; Tervaert JW
    Br J Rheumatol; 1998 Aug; 37(8):901-7. PubMed ID: 9734683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).
    Brouwer E; Stegeman CA; Huitema MG; Limburg PC; Kallenberg CG
    Clin Exp Immunol; 1994 Dec; 98(3):448-53. PubMed ID: 7994909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-proteinase 3 antibody activation of neutrophils can be inhibited by alpha1-antitrypsin.
    Rooney CP; Taggart C; Coakley R; McElvaney NG; O'Neill SJ
    Am J Respir Cell Mol Biol; 2001 Jun; 24(6):747-54. PubMed ID: 11415941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
    Csernok E; Ahlquist D; Ullrich S; Gross WL
    Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
    Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J
    Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinase 3: substrate specificity and possible pathogenetic effect of Wegener's granulomatosis autoantibodies (c-ANCA) by dysregulation of the enzyme.
    Dolman KM; van de Wiel BA; Kam CM; Kerrigan JE; Hack CE; von dem Borne AE; Powers JC; Goldschmeding R
    Adv Exp Med Biol; 1993; 336():55-60. PubMed ID: 8296674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
    Russell KA; Fass DN; Specks U
    Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant proteinase 3 produced in different expression systems: recognition by anti-PR3 antibodies.
    van der Geld YM; Oost-Kort W; Limburg PC; Specks U; Kallenberg CG
    J Immunol Methods; 2000 Oct; 244(1-2):117-31. PubMed ID: 11033024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils.
    Van Rossum AP; van der Geld YM; Limburg PC; Kallenberg CG
    Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolysis of classic anti-neutrophil cytoplasmic autoantibodies (C-ANCA) by neutrophil proteinase 3.
    Dolman KM; Jager A; Sonnenberg A; von dem Borne AE; Goldschmeding R
    Clin Exp Immunol; 1995 Jul; 101(1):8-12. PubMed ID: 7621597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener's) may reflect treatment rather than disease activity.
    Rasmussen N; Salmela A; Ekstrand A; de Groot K; Gregorini G; Cohen Tervaert JW; Gross WL; Wiik A; Jayne DR;
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S38-44. PubMed ID: 23380137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis.
    Boomsma MM; Damoiseaux JG; Stegeman CA; Kallenberg CG; Patnaik M; Peter JB; Tervaert JW
    J Immunol Methods; 2003 Mar; 274(1-2):27-35. PubMed ID: 12609530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies.
    Chen M; Yu F; Zhang Y; Zou WZ; Zhao MH; Wang HY
    Kidney Int; 2005 Nov; 68(5):2225-9. PubMed ID: 16221222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.